Trial intelligence / Profile preview

Prednisolone in Young Boys With Duchenne Muscular Dystrophy

NCT05412394Phase 4Recruiting

Start
Apr 2021
Primary completion
Aug 2028
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of prednisolone in Duchenne muscular dystrophy (DMD). Started Apr 2021; status: recruiting.

02

Drugs

prednisolone
03

Conditions

Duchenne muscular dystrophy (DMD)

Beyond the preview

Go deeper on NCT05412394.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05412394.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call